Cargando…

Conditional Survival and Cause-specific Mortality after Autologous Hematopoietic Cell Transplantation for Hematological Malignancies

The probability of survival is conventionally calculated from autologous hematopoietic cell transplantation (aHCT). Conditional survival takes into account the changing probability of survival with time survived, but is not known for aHCT populations. We determined disease-, and cause-specific condi...

Descripción completa

Detalles Bibliográficos
Autores principales:	VanderWalde, Ari M., Sun, Can-Lan, Laddaran, Lester, Francisco, Liton, Armenian, Saro, Berano-Teh, Jennifer, Wong, F. Lennie, Popplewell, Leslie, Somlo, George, Stein, Anthony S., Nademanee, Auayporn, Krishnan, Amrita, Kogut, Neil, Forman, Stephen, Bhatia, Smita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776451/ https://www.ncbi.nlm.nih.gov/pubmed/23183426 http://dx.doi.org/10.1038/leu.2012.311

Ejemplares similares

Association between Clonal Hematopoiesis and Late Nonrelapse Mortality after Autologous Hematopoietic Cell Transplantation
por: Slavin, Thomas P., et al.
Publicado: (2019)

Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation
por: Mascarenhas, Kristen, et al.
Publicado: (2019)

Personalized Medicine in Oncology; a Special Issue of the Journal of Personalized Medicine
por: VanderWalde, Ari
Publicado: (2021)

Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
por: Chang, Ellen K., et al.
Publicado: (2021)

Health Behaviors and Cancer Screening Practices in Long-term Survivors of Hematopoietic Cell Transplantation (HCT): A Report from the Bone Marrow Transplant Survivor Study (BMTSS)
por: Armenian, Saro H., et al.
Publicado: (2011)

Abnormal body composition is a predictor of adverse outcomes after autologous haematopoietic cell transplantation
por: Armenian, Saro H., et al.
Publicado: (2020)

Telehealth exercise to Improve Physical function and frailty in patients with multiple myeloma treated with autologous hematopoietic Stem cell transplantation (TIPS): protocol of a randomized controlled trial
por: Lee, Kyuwan, et al.
Publicado: (2022)

Comparison of Chemotherapy vs Chemotherapy Plus Total Hysterectomy for Women With Uterine Cancer With Distant Organ Metastasis
por: Wang, Yuefeng, et al.
Publicado: (2021)

Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study
por: Armenian, Saro H., et al.
Publicado: (2022)

Impact of Tailored Education on Awareness of Personal Risk for Therapy-Related Complications Among Childhood Cancer Survivors
por: Landier, Wendy, et al.
Publicado: (2015)

Prediction of Coronary Heart Disease Events in Blood or Marrow Transplantation Recipients
por: Gangaraju, Radhika, et al.
Publicado: (2023)

Late‐occurring infections in a contemporary cohort of hematopoietic cell transplantation survivors
por: Sy, Andrew, et al.
Publicado: (2021)

Conditioning intensity and probability of live birth after blood or marrow transplantation, a BMTSS report
por: Balas, Nora, et al.
Publicado: (2022)

Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model
por: Gangaraju, Radhika, et al.
Publicado: (2021)

Feasibility of implementing a supervised telehealth exercise intervention in frail survivors of hematopoietic cell transplantation: a pilot randomized trial
por: Lee, Kyuwan, et al.
Publicado: (2023)

Precision Medicine in Oncology: A Review of Multi-Tumor Actionable Molecular Targets with an Emphasis on Non-Small Cell Lung Cancer
por: Stein, Matthew K., et al.
Publicado: (2021)

Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)
por: Krishnan, A, et al.
Publicado: (2009)

Risk of COVID-19 infection in long-term survivors of blood or marrow transplantation: a BMTSS report
por: Johnston, Emily E., et al.
Publicado: (2023)

Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer
por: Chao, Chun, et al.
Publicado: (2019)

Chronic Comorbidities Among Survivors of Adolescent and Young Adult Cancer
por: Chao, Chun, et al.
Publicado: (2020)

Developing an electronic geriatric assessment to improve care of older adults with cancer receiving radiotherapy
por: VanderWalde, Noam A., et al.
Publicado: (2020)

Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation
por: Chen, Robert W., et al.
Publicado: (2018)

Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting
por: VanderWalde, Ari, et al.
Publicado: (2020)

Risky health behaviors and subsequent late mortality after blood or marrow transplantation: a BMTSS report
por: Balas, Nora, et al.
Publicado: (2023)

Neighborhood disadvantage, health status, and health care utilization after blood or marrow transplant: BMTSS report
por: Wolfson, Julie A., et al.
Publicado: (2022)

Phase 1 results of a phase 1b/2, multicenter, open-label trial to evaluate safety and efficacy of talimogene laherparepvec (T-VEC) and ipilimumab (ipi) vs ipi alone in previously untreated, unresected stage IIIB-IV melanoma
por: Puzanov, Igor, et al.
Publicado: (2013)

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma
por: Herrera, Alex F., et al.
Publicado: (2021)

P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma
por: Kambhampati, Swetha, et al.
Publicado: (2022)

Protective Effect of HLA-DPB1 Mismatch Remains Valid in Reduced-Intensity Conditioning Unrelated Donor Hematopoietic Cell Transplantation
por: Malki, Monzr M. Al, et al.
Publicado: (2019)

P112: Phase II Trial of Brentuximab Vedotin plus ibrutinib in Relapsed/Refractory Hodgkin Lymphoma
por: Mei, Matthew, et al.
Publicado: (2022)

Late Effects in Survivors of Acute Leukemia Treated with Hematopoietic Cell Transplantation: a Report from the Bone Marrow Transplant Survivor Study
por: Baker, K. Scott, et al.
Publicado: (2010)

Rationale and design of the Children’s Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure
por: Armenian, Saro H., et al.
Publicado: (2016)

Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell Transplant
por: Rhee, June-Wha, et al.
Publicado: (2023)

Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood Cancer
por: Armenian, Saro H., et al.
Publicado: (2012)

Treatment of allosensitized patients receiving allogeneic transplantation
por: Ciurea, Stefan O., et al.
Publicado: (2021)

Feasibility and Safety of Diffusing Alpha-Emitter Radiation Therapy for Recurrent or Unresectable Skin Cancers
por: D’Andrea, Mark A., et al.
Publicado: (2023)

Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer
por: Somlo, G, et al.
Publicado: (2002)

Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy
por: Nakamura, Ryotaro, et al.
Publicado: (2023)

Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial
por: Landier, Wendy, et al.
Publicado: (2022)

A phase II study of sirolimus, tacrolimus, and rabbit anti-thymocyte globulin as graft-versus-host prophylaxis after unrelated-donor peripheral blood stem cell transplant
por: Khaled, Samer K., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_e21i1qm1pgbi7dgta8ro9km3es